Pages that link to "Glossary:TAG-00025-Sub-mer"

The following pages link to Glossary:TAG-00025-Sub-mer:

Displaying 50 items.

• Glossary (← links)
• Reference:WMA Declaration of Helsinki 2024 - (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (c) (← links)
• Reference:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 3 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 28 (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b-002 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 9 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.7.1-001 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.1 (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 28 Paragraph 1 (f) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.60-002 (← links)
• Reference:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. B. (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 25 – 28 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 31 – 32 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.3 c) ; e) - g) (← links)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 Annex 2 2.5 (← links)
• Reference:CIOMS CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects 2016 Page 23 (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 2 (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 6-8 (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 28 Absatz 1 – 2 (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 1 1.2 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-001 (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (g) (← links)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.102 (e) (1) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (p) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.9.1 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8.13 (← links)
• Reference:CIOMS CIOMS - International Ethical Guidelines for Health-related Research Involving Humans 2016 GUIDELINE 19 (← links)
• Reference:CIOMS CIOMS - International Ethical Guidelines for Health-related Research Involving Humans 2016 GUIDELINE 18 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.3 e) - g) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 5.8.3 (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 6-001 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-002 (← links)
• Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart C (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.3 (← links)
• Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 Page 44 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 6-001 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.9.3 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - patient/subject file (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 17 (← links)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 2.1.8 (← links)
• Reference:EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 11 d) (← links)
• Reference:EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 Annex 1 (← links)
• Reference:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 2.4 - 2.5 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.7.1-002 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 6-002 (← links)
• Reference:ICH ICH E9 Guideline 1998 Glossary - Dropout (← links)
• Reference:ICH ICH E8 Guideline R1 (2021) 6.2.2 (← links)
• Reference:ICH ICH E8 Guideline R1 (2021) 4.3.3.1 (← links)